CIK 0001819253
- Accelerated filer
- Smaller reporting company
- Emerging growth company
biote Corp.
Sign in to watch- Ticker
- BTMD
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851791125
- Phone
- +1 972-486-9346
- Business address
- 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038
- Former names
- Haymaker Acquisition Corp. III
- 4 Open-market buy 10% owner bought 447,714 shares at an average $3.26 ($1,461,373)
- 4 Open-market buy 10% owner bought 1,933 shares at $3.30 ($6,371)
- 4 Open-market buy 10% owner bought 8,801 shares at $3.27 ($28,782)
- 4 Open-market buy 10% owner bought 7,874 shares at an average $3.29 ($25,906)
- 4 Open-market buy 10% owner bought 48,439 shares at an average $3.21 ($155,388)
- 4 Open-market buy 10% owner bought 74,440 shares at an average $3.19 ($237,406)
- 4/A Open-market buy 10% owner bought 856,609 shares at an average $3.25 ($2,784,419)
- 4 Open-market buy 10% owner bought 106,000 shares at $3.32 ($351,920)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 75,000 shares at an average $3.95 ($296,043)
- 4 Open-market buy Chief Executive Officer bought 37,595 shares at $3.87 ($145,493)
- 4 Open-market buy Director bought 38,104 shares at $3.88 ($147,844)
- 4 Open-market buy Director bought 107,794 shares at $3.87 ($417,163)
- 4 Open-market buy 10% owner bought 856,609 shares at an average $3.25 ($2,784,419)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 32,874 shares at $6.20 ($203,848)
- 4 Open-market sale Chief Financial Officer sold 11,376 shares at $7.57 ($86,084)
Page 2 of 7 · 138 filings